Tag Archives: Prescribing

Could reducing over-prescribing cause harm?

The lead headline in many media outlets yesterday was how GPs and the 111 system had failed in the sad case of a 1-year old, William, who died of an undiagnosed infection. I was interested to be contacted by a journalist from one paper, who asked me if I had any views on one particular …read more

Posted in Blog | Also tagged | Comments closed

Are NICE not being nice to GPs about antibiotics?

The new Antimicrobial Stewardship guidance was published this month by NICE, looking at organisational and system-wide approaches to optimising antimicrobial use. And the main message coming out of various news agencies today is that GPs will be “struck off” for not prescribing antibiotics appropriately. There is, of course, huge concern around the rising amount of …read more

Posted in Blog | Also tagged , , | Group: | Comments closed

Drug safety in a world of multimorbidity and polypharmacy

New research describes an association between use of two commonly used medications and brain haemorrhage. CCHSR’s Rupert Payne doesn’t necessarily think it’s that straightforward.

Posted in News | Also tagged , , | Group: | Comments closed

So will pharmacists save the NHS?

Well maybe, but we shouldn’t get too carried away. The RCGP and RPS have produced a joint statement of how pharmacists and GPs could work better together and the news media today are talking about an ‘army’ of pharmacists coming to the rescue of general practice. Should we be greeting the cavalry with open arms? …read more

Posted in Blog | Also tagged , | Group: , | Comments closed

Don’t incentivise withholding of antibiotics!

Don’t prescribe too many antibiotics. And just to make sure you behave, we’ll pay you not to. That’s the latest message GPs are being given by the government. I personally find this very irritating. GPs are well aware of the public health implications of prescribing too many antibiotics, and the consequent risks of antibiotic resistance. …read more

Posted in Blog, News | Also tagged , , | Group: | Comments closed

Why has the Welsh government approved Sativa for multiple sclerosis and not NICE in England?

Sativa is a nasal spray based on a cannabis extract which is used for painful muscle cramps in multiple sclerosis. There doesn’t seem much doubt that it works, and in its most recent draft guidance on MS, NICE has based it’s decision on cost effectiveness grounds – the benefit came out at £49,300 per QALY …read more

Posted in Blog | Also tagged , | Group: | Comments closed

Medication errors in primary care in the developing world

Global spending on pharmaceuticals is roughly a $1 trillion, dominated by the US, Japan and major EU economies. Yet emerging markets and the developing world still account for around a third of expenditure. That’s a lot of medicines and it’s growing. With this substantial use of medications comes a significant risk of harm, compounded by …read more

Posted in Blog | Also tagged , | Group: | Comments closed

Medicalising life

Medicines have been getting into the mainstream news quite a lot in recent times. A couple of days ago saw the publication in Annals of Oncology of a review of the evidence for a protective effect of aspirin in reducing cancer in the general population. The role of aspirin in cardiovascular disease prevention is well …read more

Posted in Blog | Also tagged , , , | Group: | Comments closed

What I read on the internet (Part V): prescribing information

Not as many links to Mumsnet this time, but just in case of interest here are some places where prescribing information or data sets for individuals, GP practices or countries can be found. INDIVIDUALS Prescribing for individuals can be purchased from commercial primary care data bases (expensive ++): QResearch http://www.qresearch.org/SitePages/Home.aspx Thin http://www.ucl.ac.uk/pcph/research-groups-themes/thin-pub/database CPRD http://www.cprd.com/intro.asp The …read more

Posted in Blog | Also tagged , | Group: | Comments closed

The King’s Fund: Polypharmacy and Medicines Optimisation

Policy, medical training and clinical practice have failed to adapt to a significant increase in the number of patients taking multiple prescription drugs, according to a new report published by The King’s Fund. CCHSR’s Rupert Payne co-authored the report, and discusses its implications.

Posted in Blog | Also tagged , , , , , | Group: | Comments closed
  • The Cambridge Centre for Health Services Research (CCHSR) is a thriving collaboration between the University of Cambridge and RAND Europe. We aim to inform health policy and practice by conducting research and evaluation studies of organisation and delivery of healthcare, including safety, effectiveness, efficiency and patient experience.